Larvol Delta - Chance-Pharmaceuticalsannounced-that-the-Center-for-Drug-Evaluation-of-China39s-National-Medical-Products-Administration-NMPA-has-accepted-the-new-drug-application-NDA-for-CXG87-Budesonide-and-Formoterol-Fumarate-Powder-for-Inhalation-IV-hard-capsule

formoterol/budesonide (CXG87) - Chance Pharma

https://www.prnewswire.com/news-releases/chance-pharma-announces-nmpa-acceptance-of-new-drug-application-for-investigational-respiratory-drug-cxg87-302766379.html

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next